Single Peptide10 mg
Tesamorelin (10 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE10 mg
RECONSTITUTION3.0 mL bacteriostatic water
CONCENTRATION~3.33 mg/mL
ROUTESubcutaneous injection
FREQUENCYOnce daily (evening preferred)
CYCLE LENGTH12–26 weeks (up to 52)
DOSE RANGE1–2 mg/day
STORAGE2–8 °C lyophilized / 2–8 °C reconstituted (use within 7 days)
Overview
Tesamorelin 10 mg vial reconstituted with 3.0 mL for ~3.33 mg/mL. The 2 mg daily dose is the standard FDA-approved regimen. A one-week titration at 1 mg may improve tolerability.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Week 1 | 1 mg / 1000 mcg | 30 units | 0.30 mL |
| Weeks 2–12+ | 2 mg / 2000 mcg | 60 units | 0.60 mL |
Reconstitution Instructions
1.
Draw 3.0 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C, protected from light.
5.
Use within 7 days when reconstituted with bacteriostatic water.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Peptide Vials (Tesamorelin, 10 mg): 11 vials (105 mg total)
- ✓Insulin Syringes (U-100): 56 syringes
- ✓Bacteriostatic Water (10 mL): 4 bottles (33 mL needed)
- ✓Alcohol Swabs: 2 × 100-count boxes
Dosing Protocol
Titration
Week 1: 1 mg daily. Weeks 2+: 2 mg daily (standard dose).
Timing
Evening administration; rotate injection sites.
Cycle Length
12–26 weeks; up to 52 weeks with monitoring.
Storage & Handling
- ✓Lyophilized: Store at 2–8 °C; newer formulations stable at room temp before reconstitution.
- ✓Reconstituted: Refrigerate at 2–8 °C; use within 7 days.
- ✓Do not freeze reconstituted solution.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Evening administration to align with nocturnal GH release.
- ✓Rotate injection sites daily.
- ✓Monitor IGF-1 levels periodically.